New therapeutic modalities for benign oesophageal disease: an overview.
Scarpignato
C
C
Laboratory of Clinical Pharmacology, School of Medicine & Dentistry, University of Parma, Italy. scarpi@tin.it
D001471:Barrett Esophagus / Q000175:diagnosis / Q000628:therapy; D002404:Catheterization / Q000379:methods*; D004931:Esophageal Achalasia / Q000175:diagnosis / Q000628:therapy; D004935:Esophageal Diseases / Q000175:diagnosis / Q000473:pathology* / Q000628:therapy*; D004932:Esophageal and Gastric Varices / Q000175:diagnosis / Q000628:therapy; D016629:Esophagectomy / Q000379:methods*; D004945:Esophagoscopy / Q000379:methods*; D005260:Female; D006801:Humans; D008026:Ligation / Q000379:methods; D008297:Male; D011379:Prognosis; D015911:Sclerotherapy / Q000379:methods*; D012680:Sensitivity and Specificity